Carotenoids have been reported to have potent antioxidant activities and to protect tissues and cells from certain diseases and environmental insults. The molecular mechanism of the action of provitamin A carotenoids such as -carotene and -cryptoxanthin is mediated in part by retinoic acid, an active form of provitamin A, but the molecular basis of the biological activities of non-provitamin A carotenoids such as lutein, zeaxanthin, and astaxanthin is not fully understood. In this study, we investigated to determine whether the actions of non-provitamin A carotenoids are mediated via retinoid signaling by monitoring retinoic acid receptor (RAR)-dependent hyaluronan production in cultured human keratinocytes. Not only -carotene and -cryptoxanthin, but also lutein, zeaxanthin, and astaxanthin, upregulated HAS3 gene expression and were followed by hyaluronan synthesis. We found that LE540, an antagonist of retinoic acid receptors, abolished lutein dependent hyaluronan synthesis and that lutein significantly increased retinoic acid responsive element (RARE)-driven transcript acitivity. In addition, we found that citral, an inhibitor of retinal dehydrogenases, decreased lutein-stimulated hyaluronan synthesis, indicating that lutein metabolites rather than lutein itself act as an RAR ligand in RARmediated transcription activity in keratinocytes. A series of non-provitamin A can be substituted for retinoids and should be considered as a potential means of improving skin health.
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Carotenoids are plant pigments with roles in photosynthesis and photoprotection. It has been found that carotenoids have antitumor, 1) photoprotective, 2) radical quenching, 3) and antioxidant 4) activities. They display these beneficial effects, as well as the ability to act as provitamin A and precursors of retinoic acid. The major provitamin A carotenoids in mammals are -carotene, -cryptoxanthin, and -carotene. In contrast, it is currently thought that non-provitamin A carotenoids including lutein, zeaxanthin, and astaxanthin, are not precursors of retinoic acid in mammals.
5)
-Carotene, a major dietary source of vitamin A, is converted to retinoic acid, an active form of vitamin A, by a series of enzymatic steps in the intestinal mucosa. 6) -Cryptoxanthin, which has a structure similar tocarotene, can also be cleaved by -carotene 15, 15 0 -monooxygenase (BCO1) to produce retinal and retinoic acid. 7) It has been reported that high doses of -carotene substantially reduced the malignant conversion of papillomae to carcinomas as well as retinoic acid. 8, 9) Because both provitamin A carotenoids and retinoids are used as potential protective agents in tumor formation, the molecular mechanisms of the action of carotenoids is probably mediated at least in part by retinoic acid.
Topical treatments of retinoic acid have been found to be beneficial to photodamaged skin. 10, 11) Retinoic acid inhibits UV-caused loss of procollagen synthesis, 12 ) the induction of matrix metalloproteinases, 13) and the tortuosity of elastic fibers. 14) In addition to these effects, it increases the synthesis of epidermal hyaluronan, 15, 16) a high molecular mass glycosaminoglycan that might support epidermal homeositasis by maintaining the extracellular space, facilitating the exchange of nutrients and waste products. 17) This suggests the possible involvement of hyaluronan in retinoic acidinduced repair, because hyaluronan has been reported to be closely involved in keratinocyte proliferation and differentiation. [18] [19] [20] Hyaluronan is synthesized by hyaluronan synthase proteins (HAS1, HAS2, and HAS3) at the inner surface of the plasma membrane. 21) In human epidermal keratinocytes, HAS3 mRNA is dominantly expressed and primarily regulates hyaluronan synthesis. [22] [23] [24] Induction of HAS3 gene expression by -carotene stimulation was also found in keratinocytes. 25) Since the expression of BCO1 7, 26) and the conversion from retinal to retinoic acid have been confirmed in the skin, 27 ) the molecular mechanism of action of provitamin A is probably mediated by retinoic acid receptors (RARs) in the keratinocytes.
On the other hand, non-provitamin A carotenoids have also been found to have physiological activities. Suppression of mouse skin papilloma 28) and morphological changes in human mammary cells 29) were observed in response not only to -carotene, but also to canthaxanthin, a non-provitamin A carotenoid. These effects have been observed in response to both provitamin A and non-provitamin A, suggesting that retinoidlike metabolites converted from non-provitamin A act in these biological effects. Recently, Sangeetha reported that astaxanthin, a non-provitamin A carotenoid, is converted to -carotene and retinol in retinol-deficient rats, 30) but the details as to where and how astaxanthin is converted to retinoids have remained obscure.
In view of the above, we hypothesized that nonprovitamin A can be converted to carboxylic acids corresponding to retinoic acid in the skin, and have similar functions.
In the present study, we examined the effects of nonprovitamin A carotenoids on hyaluronan production in human keratinocytes. Furthermore, we sought to determine whether the physiological effects of non-provitamin A carotenoids in cultured keratinocytes is due to RAR activation.
Materials and Methods
Chemicals and materials. Human foreskin keratinocytes and bovine pituitary extracts (BPE) were purchased from Kurabo (Osaka, Japan). MCDB153 medium, LE540, and Am80 were from Wako Pure Chemical (Osaka, Japan). -Cryptoxanthin, lutein, zeaxanthin, astaxanthin, lycopene, -ionone, -ionone, and citral were from Extrasynthese (Genay, France). Phytoene was from Carotenature (Lupsingen, Switzerland). All-trans retinoic acid, all-trans retinal, and -carotene were from Sigma (St. Louis, MO). Ch55 was from Tocris Bioscience (Bristol, UK).
Cell culture. Human epidermal keratinocytes were grown routinely in MCDB153 (0.1 mM Ca 2þ ) supplemented with 5 mg/L of insulin, 180 mg/L hydrocortisone, 14.1 mg/L O-phosphorylethanolamine, 6.1 mg/L 2-aminoethanol, 100 ng/L EGF, and 0.4% (vol/vol)BPE. When the cells reached confluence, they were subcultured in either 24-well plates or 12-well plates in the same medium. After subculturing, the cells were confluent and the medium was exchanged for an identical medium, except that hydrocortisone and EGF were depleted and BPE was reduced to a concentration of 0.04%. Agents were added to the medium and cultured for the time of indicated in the legends to the figures. The conditioned media of the 24-well plates were assayed for hyaluronan production, and the cells were used in RT-PCR analyses. The cells of the 12-well plates were used in secreted alkaline phosphatase (SEAP) reporter assays.
RT-PCR. Total RNA from the cultured cells was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) folloing the manufacturer's recommended protocol. The reaction was carried out with a Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics, Mannheim, Germany). The following primer sets were used in PCR analysis: HAS3 sense:
0 . These primers were designed to span exons using Primer3. The PCR cycles and amplified product sizes were as follows: HAS3, 25 cycles, 488 bp, and G3PDH, 22 cycles, 452 bp. Amplified cDNAs were analyzed on a 2% agarose gel containing ethidium bromide. A 100 bp-DNA ladder standard was used as size marker.
Measurements of hyaluronan production. Hyaluronan levels were was measured by sandwich assay, as described previously. 31) Briefly, 96-well plates were precoated with hyaluronan binding protein (HABP) (Seikagaku, Tokyo) to catch hyaluronan from the samples and standards. After washing, HABP-labeled with an EZ-Link Maleimide Activated Horseradish Peroxidase Kit (Pierce, Rockford, IL) was added to detect bound hyaluronan for spectrophotometric quantification at 420 nm with a 3,3 0 ,5,5 0 -tetramethylbenzidine (TMB) substrate solution (Moss, Pasadena, MD).
Assay for DNA. DNA was measured using fluorescent reagent 3, 5-diaminobenzoic acid, as described by Johnson-Wint and Hollis. 32) SEAP reporter assay. The RARE reporter construct pRARE-TA-SEAP contains 2 copies of a RARE sequence upstream of the minimal TA promoter, and contains a SEAP promoter gene driven by an SV40 promoter (Clontech, Palo Alto, CA). A pSEAP2-Basic vector (Clontech) containing a SEAP gene without a promoter was used as negative control to measure the background signal associated with the cell culture media. Keratinocytes in a 12-well plate were transfected with pRARE-TA-SEAP or pSEAP2-Basic vector with Fugene 6 transfection reagent (Roche Diagnostics, Mannheim, Germany), as indicated in the manual. After transfection for 24 h, the cells were treated with lutein and incubated for 24 h. SEAP activities in the conditioned media were measured by the EscApe SEAP chemiluminescence detection system (Clontech) and Luminescencer PSN AB2200 (ATTO, Tokyo).
Statistical analysis. Results were expressed as means AE SD. All statistical calculations were performed using SAS Ò software. The data were analyzed using Dunnett's multiple comparison test. Dose dependency was determined by the Williams test. A p value of less than 0.05 was considered to be statistically significant.
Results

Effects of carotenoids on HAS3-mediated hyaluronan synthesis in keratinocytes
We evaluated hyaluronan synthesis in human keratinocytes by various carotenoids, including -carotene as positive control, 25) and related compounds to investigate structure-activity relationships (Fig. 1) . The structure of each of the compounds investigated is shown in Fig. 2 .
Hyaluronan increased significantly when keratinocytes were exposed not only to the provitamin A carotenoids -carotene and -cryptoxanthin, but also to non-provitamin A carotenoids lutein, zeaxanthin, and astaxanthin (Fig. 1a) . In contrast, lycopene, phytoene, -ionone, and -ionone did not exhibit significant cytes. a, Confluent human keratinocytes were incubated for 48 h in the absence and the presence of -carotene, -cryptoxanthin, lutein, zeaxanthin, and astaxanthin at a concentration of 5 mM. Hyaluronan levels were measured as described in ''Materials and Methods.'' Values represent mean AE SD for three replicate assays. Significantly different from the control value:
Ã p < 0:05, ÃÃÃ p < 0:001 (Dunnett's test). Total RNA was extracted and subjected to RT-PCR. The PCR products were visualized in a 2% agarose gel stained with ethidium bromide. b, Human keratinocytes were cultured with various concentrations of lutein (0.3-5 mM) for 48 h. Hyaluronan assay and RT-PCR were carried out as described above. Significantly different from the control value:
ÃÃ p < 0:01 (Williams test). c, Human keratinocytes were cultured with 5 mM lutein for various times. Total RNA was analyzed as described above. activity (254, 183, 274, and 274 ng/well respectively as compared to the control, 288 ng/well), suggesting that both cyclohexene rings and polyene moieties are necessary to induce hyaluronan synthesis. The stimulation of hyaluronan synthesis by carotenoids was accompanied by an increase in the level of HAS3 mRNA (Fig. 1a) .
Among the non-provitamin A carotenoids tested, we focused on lutein to investigate in detail how nonprovitamin A can stimulate hyaluronan synthesis via upregulation of HAS3 gene expression. Lutein showed a dose-dependent increase in hyaluronan production with a corresponding increase in HAS3 gene expression at a concentration of 1 to 5 mM (Fig. 1b) . Under these conditions, the addition of lutein did not induce notable alterations in DNA content (Supplemental Fig. 1 ; see Biosci. Biotechnol. Biochem. Web site), indicating that the effects of lutein on hyaluronan synthesis were independent of cell proliferation. Upregulation of HAS3 mRNA expression was observed at 2 h after the addition of lutein and increased time-dependently (Fig. 1c) .
Effects of lutein on RAR activation
To assess whether hyaluronan synthesis is induced by lutein via RARs, the effect of LE540, a panantagonist for RARs, 33) was investigated. Hyaluronan production induced by lutein as well as -carotene was completely abolished by LE540 treatment, although basal hyaluronan production was also partially reduced (Fig. 3a) . Additionally, the capacity of lutein to activate RARs was investigated by SEAP reporter assay. Lutein significantly increased RARE-driven SEAP activity in a reasonable range of concentrations to stimulate hyaluronan production in a dose-dependent manner (Fig. 3b) . These results indicate that lutein or its metabolites serve as a ligand for RARs in keratinocytes. We have confirmed that zeaxanthin, a non-provitamin A carotenoid, and -carotene, a provitamin A carotenoid, also increased SEAP activity (Supplemental Fig. 2) . These results suggest that nonprovitamin A carotenoids such as lutein and zeaxanthin or their metabolites serve as a ligand for RARs in human keratinocytes.
Effects of citral on hyaluronan synthesis induced by lutein
Keratinocytes can convert retinal into retinoic acid.
27)
We treated cells with lutein in the presence and the absence of citral, 34) an inhibitor of retinal dehydrogenases (RALDHs) that converts retinal to retinoic acid, and estimated hyaluronan production. Citral did not affect retinoic acid-induced hyaluronan production, whereas it inhibited the effects of lutein as well as retinal (Fig. 4) . This suggests that a non-provitamin A carotenoid, lutein, is oxidatively cleaved to aldehydes, followed by RALDH-dependent oxidative formation of carboxylic acids corresponding to retinoic acid, a metabolic process similar to that of provitamin A carotenoids. The carotenoids used in this study were in the all-trans configuration. 
Discussion
The present study provides for the first time evidence that lutein, a non-provitamin A carotenoid, activates RARs in keratinocytes. We investigated the RAR stimulation activity of non-provitamin A by monitoring keratinocyte hyaluronan production, because retinoic acid can induce HAS3 mRNA followed by hyaluronan production in human keratinocytes. 25) Hyaluronan synthesis induced by -carotene, a provitamin A, was inhibited by LE540, an RAR pan-antagonist. Since RAR-isoforms are expressed in keratinocytes, 35, 36) alltrans retinoic acid converted from -carotene in cells can act as an RAR ligand to activate transcription. This indicates that -carotene involves retinoid signaling and is metabolized in keratinocytes to retinoids with biological activity.
Under the same conditions, we found that LE540 completely abolished lutein-dependent hyaluronan synthesis, to the control level. Furthermore, treatment with lutein significantly increased RARE-driven transcript activity, suggesting that lutein or its metabolites serve as a ligand for RARs in keratinocytes.
Matsumoto et al. have reported that lutein bound to RAR in a cell-free CoA-BAP system, 37) and it seems likely that lutein itself can substitute for retinoic acid. In order to ascertain which of lutein and its metabolites is functioning as a ligand for RARs in keratinocytes, we estimated the effect of citral, an inhibitor of RALDH, on lutein-dependent action. The RALDH protein has been observed throughout the epidermis with equivalent expression in all keratinocyte layers, 38) and we confirmed that RALDH3 mRNA was predominantly expressed among the isoforms of RALDHs in cultured keratinocytes (data not shown). In the present study, we found that citral significantly decreased lutein-dependent hyaluronan synthesis. This suggests that lutein is oxidatively cleaved to aldehydes by BCO1 or similar monooxygenases, followed by RALDH-dependent oxidative formation of carboxylic acids corresponding to retinoic acid (Fig. 5) , a metabolic process similar to that of provitamin A carotenoids. In sum, lutein metabolites rather than lutein itself act as an RAR ligand and stimulate RAR-mediated transcription activity in the keratinocytes.
The conversion of astaxanthin to retinol in a murine model 39) has been reported. More recently, Sangeetha et al. also reported that astaxanthin was converted to -carotene and retinol in retinol-deficient rats. 30) This indicates that non-provitamin A taken orally can be converted to retinoids, although the possibility of intestinal bacteria contributing to conversion cannot be excluded. We found that human epidermal keratinocytes can convert lutein oxidatively to carboxylic acids corresponding to retinoic acid, and that the metabolites act as an RAR ligand. The structure of lutein metabolites as RAR ligands requires further investigation.
Of RAR families, it has been reported that RAR is predominantly expressed in the epidermis. 36) Am80, a selective agonist for RAR and RAR , 40) induced hyaluronan synthesis in the same way as Ch55, a panagonist of RAR (Supplemental Fig. 3 ), suggesting that RAR is not the only receptor responsible for all-trans retinoic acid in keratinocytes.
LE540 reduced basal hyaluronan synthesis in the keratinocytes. Bovine pituitary extract (BPE), a supplement for keratinocyte growth, might influence RARdependent hyaluronan synthesis because retinoic acid is a regulatory factor in pituitary function and is generated in the anterior pituitary gland. 41) Lutein and zeaxanthin are the predominant carotenoids found in the human retina, and they are known to be essential dietary nutrients for macular pigment. 42) They have also been to accumulate in the skin, 43) and have superior antioxidant properties. They have been found to inhibit the auto-oxidation of cellular lipids 44) and to protect cells from oxidant-induced damage. 45) In in vivo studies, oral intake of lutein and zeaxanthin had protective effects against epidermal inflammation, 46) photoaging, and photocarcinogenesis 47) under UVB exposure. Moreover, topical administration of these two carotenoids provided significant effects in terms of skin elasticity and hydration, and induced reductions in skin lipid peroxidation. 48) Taken together with our findings, it appears that not only the antioxidant activity of lutein and zeaxanthin but also RAR activation by their metabolites might contribute to the protective process of various clinical effects.
In conclusion, the present study indicates that metabolites of lutein in keratinocytes exhibit agonist activity for RARs, inducing hyaluronan synthesis. A series of non-provitamin As can be substituted for retinoids, and should be considered as potential candidates to improve skin health.
